# CSII Versus MDI in Pregnant Women With Type 2 Diabetes

> **NCT05001815** · NA · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Type 2 Diabetes
- Pregnancy in Diabetic

## Interventions

- **DEVICE:** Continuous subcutaneous insulin infusion (CSII)
- **DEVICE:** Multiple daily insulin injection (MDI)

## Key facts

- **NCT ID:** NCT05001815
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-15
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05001815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05001815, "CSII Versus MDI in Pregnant Women With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05001815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*